Pain (short‐term) Pain index1. Scale from: 0 to 70. · participants with acute or subacute low‐back pain
1 finding from 1 review
Duration of sick‐leave Sick‐leave > 21 days · participants with acute or subacute low‐back pain
It is very uncertain whether back school changes duration of sick‐leave Sick‐leave > 21 days compared with short‐wave diathermy at the lowest intensity (very low certainty).
1 finding from 1 review
Intervention not reported
Clinical outcome: systolic blood pressure (automated sphygmomanometer or electronic pressure monitor) ATCS Plus or IVR versus usual care at median · patients with hypertension
1 finding from 1 review
Intervention not reported
Clinical outcome: diastolic blood pressure (automated sphygmomanometer and electronic cuff) ATCS Plus, unidirectional versus usual care at median · patients with hypertension
1 finding from 1 review
Intervention not reported
Clinical outcome: blood pressure control, 26 weeks Multimodal/complex interventionf versus usual care · patients with hypertension
1 finding from 1 review
Intervention not reported
Clinical outcome: Health statush, depressioni, 6 weeks ATCS Plus versus enhanced usual care (plus information) · patients with hypertension
1 finding from 1 review
Intervention not reported
Behavioural outcome: medication use Multimodal/complexk, ATCS Plus versus usual care or enhanced usual care (plus information) · patients with hypertension
1 finding from 1 review
Intervention not reported
Behavioural outcome: physical activity levels, 12 weeks IVR versus enhanced usual care · patients with hypertension
1 finding from 1 review
Intervention not reported
Adverse outcome: unintended adverse events attributable to the intervention Multimodal/complex intervention, ATCS Plus, IVR, unidirectional ATCS versus various controls · patients with hypertension
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
HRQOL ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Participant‐assessed improvement in rosacea severity · Participants with rosacea
1 finding from 1 review
Proportion of participants with adverse event Pain as · Participants with rosacea
1 finding from 1 review
Physician‐assessed improvement in rosacea severity ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Assessment of erythema or telangiectasia · Participants with rosacea
1 finding from 1 review
Lesion count ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Time needed until improvement ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Duration of remission ‐ not measured · Participants with rosacea
The review found no eligible studies for this question.
1 finding from 1 review
Participant‐reported pain relief of 50% or greater · intensive care unit in India
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · intensive care unit in India
1 finding from 1 review
no estimate extracted
24 participants
Very low
Sedation score (numerical rating scale of 1 to 6: 0 = anxious, agitated, or restless, 6 = asleep, no response) · intensive care unit in India
1 finding from 1 review
no estimate extracted
24 participants
Very low